GB202019954D0 - Treatment regimens for early idiopathic Parkinson's Disease - Google Patents

Treatment regimens for early idiopathic Parkinson's Disease

Info

Publication number
GB202019954D0
GB202019954D0 GBGB2019954.3A GB202019954A GB202019954D0 GB 202019954 D0 GB202019954 D0 GB 202019954D0 GB 202019954 A GB202019954 A GB 202019954A GB 202019954 D0 GB202019954 D0 GB 202019954D0
Authority
GB
United Kingdom
Prior art keywords
disease
treatment regimens
idiopathic parkinson
early
early idiopathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2019954.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bial Portela and Cia SA
Original Assignee
Bial Portela and Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela and Cia SA filed Critical Bial Portela and Cia SA
Priority to GBGB2019954.3A priority Critical patent/GB202019954D0/en
Publication of GB202019954D0 publication Critical patent/GB202019954D0/en
Priority to JP2023536970A priority patent/JP2024500754A/en
Priority to KR1020237023456A priority patent/KR20230118933A/en
Priority to PCT/PT2021/050044 priority patent/WO2022131944A1/en
Priority to EP21840202.2A priority patent/EP4262798A1/en
Priority to US18/201,920 priority patent/US20230390267A1/en
Priority to US18/370,005 priority patent/US20240000762A1/en
Ceased legal-status Critical Current

Links

GBGB2019954.3A 2020-12-17 2020-12-17 Treatment regimens for early idiopathic Parkinson's Disease Ceased GB202019954D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB2019954.3A GB202019954D0 (en) 2020-12-17 2020-12-17 Treatment regimens for early idiopathic Parkinson's Disease
JP2023536970A JP2024500754A (en) 2020-12-17 2021-12-17 Treatment regimens for early idiopathic Parkinson's disease
KR1020237023456A KR20230118933A (en) 2020-12-17 2021-12-17 Treatment regimen for early idiopathic Parkinson's disease
PCT/PT2021/050044 WO2022131944A1 (en) 2020-12-17 2021-12-17 Treatment regimens for early idiopathic parkinson's disease
EP21840202.2A EP4262798A1 (en) 2020-12-17 2021-12-17 Treatment regimens for early idiopathic parkinson's disease
US18/201,920 US20230390267A1 (en) 2020-12-17 2023-05-25 Treatment regimens for early idiopathic parkinson's disease
US18/370,005 US20240000762A1 (en) 2020-12-17 2023-09-19 Treatment regimens for early idiopathic parkinson's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2019954.3A GB202019954D0 (en) 2020-12-17 2020-12-17 Treatment regimens for early idiopathic Parkinson's Disease

Publications (1)

Publication Number Publication Date
GB202019954D0 true GB202019954D0 (en) 2021-02-03

Family

ID=74221317

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2019954.3A Ceased GB202019954D0 (en) 2020-12-17 2020-12-17 Treatment regimens for early idiopathic Parkinson's Disease

Country Status (1)

Country Link
GB (1) GB202019954D0 (en)

Similar Documents

Publication Publication Date Title
SG11201912154XA (en) Aadc polynucleotides for the treatment of parkinson's disease
IL274648A (en) New catecholamine prodrugs for use in the treatment of parkinson's disease
IL290693A (en) Neuromelanin-sensitive mri for assessing parkinson's disease
IL278178A (en) Use of pilocarpine hydrochloride for the treatment of ocular conditions
SG11202011296VA (en) Compositions and methods for the treatment of parkinson's disease
ZA200909191B (en) Catecholamine derivatives useful for the treatment of parkinson's disease
EP4196113A4 (en) Pharmaceutical compositions and methods for treating parkinson's disease
IL277182A (en) Compositions and methods for treating parkinson's disease
IL287523A (en) Compositions useful for treatment of pompe disease
EP3954395A4 (en) Pharmaceutical composition for muscle disease treatment
EP4171539A4 (en) Compositions and methods for treating alzheimer's disease and parkinson's disease
PL3463351T3 (en) Treatment for parkinson's disease
IL283654A (en) Decarboxylase inhibitors for treating parkinson's disease
ZA202205344B (en) Gene therapy for alzheimer's disease
IL284344A (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
EP3902539A4 (en) Methods for treating parkinson's disease by administering resiniferatoxin
GB202016425D0 (en) Treatment regimens for parkinson's disease
GB202109826D0 (en) Treatment regimens for early idiopathic parkinson's disease
GB202106133D0 (en) Treatment regimens for early idiopathic Parkinson's Disease
GB202019954D0 (en) Treatment regimens for early idiopathic Parkinson's Disease
SG11202102369VA (en) Compositions and methods for the treatment of parkinson's disease
CO2023009085A2 (en) Levodopa dosage regimen
GB202212082D0 (en) Treatment regimens for parkinson's disease
IL309468A (en) Biomarkers for alzheimer's disease treatment
IL290726A (en) Use of brazikumab to treat crohn's disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)